Komen California Recognizes National Metastatic Breast Cancer Day

Nonprofit to host video conference focused on enhanced research for
lethal breast cancer

SACRAMENTO, Calif.–(BUSINESS WIRE)–#BreastCancer–Susan G. Komen California Affiliates will be holding a video conference
on October 13 from 11 a.m. to 1:30 p.m. in recognition of National
Metastatic Breast Cancer Day. This special statewide video presentation
is provided at no cost to participants and open to anyone with an
interest in metastatic breast cancer, including those who are living
with it, co-survivors, health care providers and community health
organizations, and aims to elevate public awareness and understanding of
metastatic breast cancer.

Metastatic breast cancer, also called stage IV or advanced breast
cancer, is breast cancer that has spread beyond the breast to other
organs in the body – most often the bones, lungs, liver or brain. On
average, survival for metastatic breast cancer varies greatly from
person to person, with one study finding about 37 percent of women lived
at least three years after diagnosis with metastatic breast cancer. Some
women may live 10 or more years beyond diagnosis, which means investing
in earlier detection, diagnosis and treatment of breast cancer could
save many more lives. The emphasis on metastatic breast cancer is a
major component of Komen’s goal to reduce the current number of breast
cancer deaths in the U.S. by 50 percent in 10 years.

“Today, we know that the majority of breast cancer deaths are likely the
result of metastatic breast cancer,” said Komen Sacramento Executive
Director, Kelly Mac Millian. “This is why it’s so critical to support
research that will help us understand more about metastasis and them to
develop effective ways to treat it.”

Hosted by Komen Sacramento, the Metastatic Breast Cancer Video
Conversation will also include affiliates from Los Angeles and San
Diego, and will cover topics ranging from advanced research into new
treatments for aggressive and metastatic disease, to what Komen is doing
to seek to out next-generation technologies to prevent breast cancer
recurrence and metastasis.

Event speakers will include:

  • Rebecca Birch, Public Policy Specialist, Susan G. Komen
  • Audrey Millemann, Chair of the Komen CA Collaborative Public
    Policy Committee
  • Shyrea Thompson, Senior Manager, Special Initiatives,
    Susan G. Komen
  • Leah Barros, Associate Lobbyist , Political Solutions
  • Dr. Richard Williams, Clinical Professor of Medicine at the
    UCLA School of Medicine and President/CEO of the Minority Health
    Institute, and President – National Medical Association
  • Dr. Khadijah Lang, President, Golden State Medical Association;
    Founder and Medical Director – Lang Family Practices
  • Dr. T. Que Collins, Principal Scientist – Cignature Health
  • Dr. Robert Abraham, Senior Vice-President and Group Head,
    Oncology – Pfizer La Jolla

To register for the video conference, please visit: https://www.eventbrite.com/e/a-mission-to-end-breast-cancer-tickets-28176828653.

Limited seats are available to attend in person sessions in Sacramento,
Los Angeles and San Diego. Those who are interested are encouraged to
reserve a seat by contacting one of the following Komen representatives:

Susan G. Komen Sacramento Valley services 19 counties in the northern
California region. Since 1997, Komen Sacramento has awarded over $18
million to local organizations for innovative breast health and breast
cancer services not found elsewhere– serving the uninsured and under
insured for screening, education and treatment. For more information
about Susan G. Komen Sacramento Valley, visit komensacramento.org.

Contacts

for Susan G. Komen Sacramento Valley
Jayme Ghisletta, 209-604-7847
jghisletta@prosiopr.com

Recibe gratis todas las noticias en tu correo

Este sitio está protegido por reCAPTCHA y Google Política de privacidad y Se aplican las Condiciones de servicio.

¡Muchas gracias! Ya estás suscrito a nuestro newsletter

Más sobre este tema
Contenido Patrocinado
Enlaces patrocinados por Outbrain